内分泌学と糖尿病の研究

Metabolism and Metabonomics in Cancer Risk Assessment, Diagnosis, Prognosis and Treatment

M. Čuperlović-Culf

Metabolism and Metabonomics in Cancer Risk Assessment, Diagnosis, Prognosis and Treatment

Cancer is a genetic disease – changes to the cell’s DNA lead to malignant transformation and known hallmarks of cancer. Genetic or epigenetic mutations leading to altered expression levels and activation of oncogenes and oncosuppressor genes reprogram metabolism as well and this further promotes tumor progression. There are now many experimental and clinical proofs of the significance of cancer metabolic phenotype in cancer’s development, growth and metastasis.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません